SCHEMBL7778150

SCHEMBL7778150

C#CCn1cc(-c2ccc(Cl)cc2)c(-c2ccc(S(N)(=O)=O)cc2)n1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 10/20 0.49
PTGS1 P23219 4/20 0.49
CA12 O43570 9/20 0.47
CA1 P00915 9/20 0.47
CA2 P00918 9/20 0.47
CA9 Q16790 9/20 0.47
CA3 P07451 1/20 0.44
CA4 P22748 1/20 0.44
CA6 P23280 1/20 0.44
CA5A P35218 1/20 0.44
CA7 P43166 1/20 0.44
CA13 Q8N1Q1 1/20 0.44
CA14 Q9ULX7 1/20 0.44
CA5B Q9Y2D0 1/20 0.44
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7778030 0.89 PTGS2 (0.48) PTGS2PTGS1CA12CA1CA2
SCHEMBL7780847 0.89 CA1 (0.49) PTGS2PTGS1CA12CA1CA2
SCHEMBL7780784 0.88 PTGS2 (0.51) PTGS2PTGS1
SCHEMBL7780380 0.88 PTGS2 (0.51) PTGS2PTGS1CA12CA1CA2
SCHEMBL7777650 0.88 CA9 (0.47) PTGS2PTGS1CA12CA1CA2
SCHEMBL7779955 0.85 PTGS2 (0.51) PTGS2PTGS1CA12CA1CA2
SCHEMBL7772832 0.85 MEN1 (0.54) PTGS2PTGS1CA12CA1CA2
SCHEMBL7779740 0.83 CA1 (0.50) PTGS2PTGS1CA12CA1CA2
SCHEMBL7777956 0.82 PTGS2 (0.48) PTGS2PTGS1CA12CA1CA2
SCHEMBL7780480 0.82 PTGS2 (0.55) PTGS2PTGS1CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed